SCHEMBL12644492

SCHEMBL12644492

COc1cc(CCc2cc(Br)c(O)c(Br)c2)cc(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 2/20 0.56
▸ CALM1 P0DP23 8/20 0.51
▸ CYP19A1 P11511 1/20 0.50
▸ GABRA1 P14867 1/20 0.49
▸ GABRG2 P18507 1/20 0.49
▸ GABRB3 P28472 1/20 0.49
▸ GABRA3 P34903 1/20 0.49
▸ GABRA2 P47869 1/20 0.49
▸ GABRB2 P47870 1/20 0.49
▸ PTGS2 P35354 2/20 0.46
▸ PTPN1 P18031 1/20 0.45
▸ NOS2 P35228 1/20 0.45
▸ DAO P14920 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ ALOX5 P09917 1/20 0.41
▸ FGFR1 P11362 1/20 0.40
▸ KDR P35968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13552161 0.90 DAO (0.50) AKR1B1CALM1CYP19A1GABRA1GABRG2
SCHEMBL1119249 0.83 ALOX5 (0.54) PTGS2ALDH1A1ALOX5
SCHEMBL9491787 0.81 CYP19A1 (0.68) AKR1B1CALM1CYP19A1GABRA1GABRG2
SCHEMBL7873997 0.81 CYP3A4 (0.55) GABRA1GABRA2GABRB2PTPN1ALDH1A1
SCHEMBL16602200 0.78 AKR1B1 (0.61) AKR1B1CALM1CYP19A1GABRA1GABRG2
SCHEMBL4735081 0.74 CALM1 (0.73) AKR1B1CALM1CYP19A1GABRA1GABRG2
SCHEMBL28768945 0.74 AKR1B1 (0.53) AKR1B1CALM1CYP19A1GABRA1GABRG2
SCHEMBL16601910 0.73 PTPN1 (0.53) AKR1B1CALM1CYP19A1GABRA1GABRG2
SCHEMBL8990149 0.73 GABRA1 (0.52) GABRA1GABRA2GABRB2PTGS2ALDH1A1
SCHEMBL919408 0.73 AKR1B1 (0.55) AKR1B1CALM1CYP19A1GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9771321-B2 Small molecules that covalently modify transthyretin THE SCRIPPS RESEARCH INSTITUTE (US) 2017-09-26 — — US disclosed
US-20170190660-A9 Small Molecules That Covalently Modify Transthyretin KELLY JEFFERY W (US) 2017-07-06 — — US disclosed
US-20140336254-A1 Small Molecules That Covalently Modify Transthyretin KELLY JEFFERY W (US) 2014-11-13 — — US disclosed
US-8703815-B2 Small molecules that covalently modify transthyretin THE SCRIPPS RESEARCH INSTITUTE (US) 2014-04-22 — — US disclosed
US-20120270938-A1 SMALL MOLECULES THAT COVALENTLY MODIFY TRANSTHYRETIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-10-25 — — US disclosed
WO-2011075210-A2 SMALL MOLECULES THAT COVALENTLY MODIFY TRANSTHYRETIN THE SCRIPPS RESEARCH INSTITUTE (US) 2011-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336254-A1 Small Molecules That Covalently Modify Transthyretin TTR, TTPA, APOB AKR1B1 715/4885CALM1 2608/4885CYP19A1 2455/4885
US-20170190660-A9 Small Molecules That Covalently Modify Transthyretin TTR, TTPA, APOB AKR1B1 715/4885CALM1 2608/4885CYP19A1 2455/4885
US-20120270938-A1 SMALL MOLECULES THAT COVALENTLY MODIFY TRANSTHYRETIN TTR, TTPA, APOB AKR1B1 715/4885CALM1 2608/4885CYP19A1 2455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback